Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00536523 · ClinicalTrials.gov registry record
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00536523 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 13 participants.
The verdict
NCT00536523 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about changes in serotonin levels in patients undergoing chemotherapy for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer may help doctors learn more about constipation caused by chemotherapy. PURPOSE: This clinical trial is studying how blood levels of serotonin effect constipation caused by chemotherapy in patients with newly diagnosed ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00536523
The ClinicalTrials.gov registry entry for NCT00536523 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00536523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00536523 about?
NCT00536523 is a clinical study titled "Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer". RATIONALE: Gathering information about changes in serotonin levels in patients undergoing chemotherapy for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer may help doctors learn more about constipation caused by chemotherapy. PURPOSE: This clinical trial is studying how blood le...
What is the current status of trial NCT00536523?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2007-04. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00536523?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.